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Background Diagnostic assessment of lung function necessitates up-to-date reference
values. The aim of this study was to estimate reference values for spirometry for the
Finnish population between 18 and 80 years and to compare them with the exist-
ing Finnish, European and the recently published global GLI2012 reference values.
Methods Spirometry was performed for 1380 adults in the population-based FinEsS
studies and for 662 healthy non-smoking volunteer adults. Detailed predefined
questionnaire screening of diseases and symptoms, and quality control of spirom-
etry yielded a sample of 1000 native Finns (387 men) healthy non-smokers aged
18–83 years. Sex-specific reference values, which are estimated using the GAMLSS
method and adjusted for age and height, are provided.
Results The predicted values for lung volumes are larger than those obtained by
GLI2012 prediction for the Caucasian subgroup for forced vital capacity (FVC) by
an average 62% and 51% and forced expiratory volume in 1 s (FEV1) by an
average 42% and 30% in men and women, respectively. GLI2012 slightly
overestimated the ratio FEV1/FVC with an age-dependent trend. Most reference
equations from other European countries, with the exception of the Swiss SAPAL-
DIA study, showed an underestimation of FVC and FEV1 to varying degrees, and
a slight overestimation of FEV1/FVC.
Conclusion This study offers up-to-date reference values of spirometry for native
Finns with a wide age range. The GLI2012 predictions seem not to be suitable
for clinical use for native Finns due to underestimation of lung volumes.
Introduction
Spirometry is the most commonly used method for assessment
of lung function. Up-to-date reference values, which reflect
the target population, are necessary. In an optimal situation,
reference values for diagnostic purposes are estimated from
randomly selected healthy subjects without any exposure to
inhaled substances known to potentially affect lung function.
Lung function depends on ethnicity due to differences in body
composition and the proportional size of thoracic cavity in
relation to height.
In Finland, the presently used reference values were derived
from a selected occupational cohort of 296 males and 257
females with a relatively narrow age range between 18 and
65 years in the late 1970s; in the age group from 60 to
65 years, only 9 men and 13 women were included (Viljanen
et al., 1982). Thus, these reference values are not appropriate
for elderly subjects and may not reflect a current healthy pop-
ulation due to changes in health-related factors in Finland.
From 1970s, the average height of the Finnish population has
increased on average almost 5 cm in both men and women, a
change reflecting generally improved level of health and nutri-
tion during childhood and adolescence (Silventoinen et al.,
1999). In addition, the reference values of Viljanen (Viljanen
et al., 1982) were compiled using a rolling-seal spirometer
coupled to an analog x-y-writer. This system has not been
used for over two decades in clinical work. The performance
of modern flow transducer devices with digital data processing
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differ in comparison with the system used by Viljanen in
terms of internal resistance, friction, time constants and
accuracy.
In 2012, Quanjer et al. (2012) presented new Global Lungs
Initiative (GLI2012) reference equations using the LMS
method. These all-age reference values provide a statistically
more valid description of the evolution of lung function from
childhood to adulthood (Cole & Green, 1992; Stanojevic et al.,
2008; Cole et al., 2009). Different racial groups were
included, but the majority of included studies were grouped
to ‘Caucasian’ despite a very large geographical variation. No
data from Finnish people were included in that material. Pre-
dicted values for lung volumes according to the ECSC are up
to 10% smaller than the current Finnish reference values (Vil-
janen et al., 1982; Quanjer et al., 1993). In Australia and
Poland, the GLI2012 values have recently been evaluated in
hospital tertiary care patients undergoing routine spirometry.
The GLI2012 prediction models were found to produce signif-
icantly larger lung volumes than the old ECSC reference values
(Quanjer et al., 2013).
In healthy subjects from across Australia and New Zealand,
the GLI2012 reference values for Caucasians have been found
to reflect current values adequately although some statistically
significant differences were found (Hall et al., 2012). The
reported z scores of around +03 (SD 10) reflect slight under-
estimation of lung volumes with GLI2012. In Tunis, a North-
ern African country which is also categorized into the same
Caucasian ethnic group as Finland, the GLI2012 reference val-
ues have recently been found to significantly overestimate
lung volumes in healthy non-smokers with z scores in the
magnitude of 06 (SD 09) (Ben Saad et al., 2013).
The aim of this study was to produce for clinical use new
reference values of flow-volume spirometry for native Finns
from healthy non-smoking adults with a wide age range
recorded with modern flow transducers and compiled with
the most recent statistical modelling. We also aimed to assess
differences between the new reference data, existing Finnish
reference values, other European reference values and the new
global GLI2012 reference values.
Methods
Study subjects were recruited from four locations (Helsinki,
Kuopio, Tampere and Kemi) in Finland representing geo-
graphically diverse populations. Thus, the subjects covered
people from southern, eastern, middle and northern Finland.
All study participants were native Finns. Uniform inclusion
and exclusion criteria were applied to include healthy and
non-smoking subjects with no morbid obesity, no occupa-
tional exposure to vapours, gases, dusts or fumes and
accepting only short previous exposure to tobacco smoke.
Approvals of the study protocols were obtained from Helsinki
University Central Hospital Coordinating Ethics Committee
(for Helsinki), Research Ethics Committee for the Hospital
District of Northern Savo (for Kuopio and Tampere) and
L€ansi-Pohja Central Hospital Ethics Committee (for Kemi). A
written informed consent was obtained from all participants.
In Tampere and Kuopio, healthy non-smokers were specif-
ically recruited for this study between 2005 and 2006 using
newspaper announcements. To find also sufficient numbers
of elderly subjects, announcements were targeted in Kuopio
to newspapers read more frequently by senior citizens. Sub-
jects were interviewed to determine eligibility for this study
using predefined criteria, which were selected to correspond
to the interview and anthropometric criteria applied to the
population samples. From the FinEsS population study (Hel-
sinki and Kemi), healthy non-smoking subjects were selected
based on the FinEsS interview questionnaire. The study pro-
tocol for the FinEsS studies has been published previously
(Kotaniemi et al., 2005; Pallasaho et al., 2006; Kainu et al.,
2008). Of the 643 participants of the FinEsS-Helsinki popu-
lation study undertaken between 2001 and 2003, 212
subjects were identified on predefined criteria healthy and
non-smoking. In Helsinki, a separate repeatability study was
conducted with 21 healthy non-smoking volunteers. Of the
FinEsS-Kemi population study undertaken between 1996 and
1999, 695 participants yielded 233 healthy non-smoking
subjects using identical screening protocol. The formation of
the study sample from the different study centres is shown
in Fig. 1.
Subjects were required not to have any diagnosed acute or
chronic pulmonary disease, cardiac disease or neurological
disability, morbid obesity, no prior chest surgery, radiother-
apy or anomalies of the thorax, no systemic diseases known
to affect respiratory function (e.g. connective tissue disease or
muscular dystrophy), no prior use of lung medication (with
the exception of temporary use of cough medication) or heart
medication potentially affecting respiratory function. Pre-
scribed use of medication was considered an indication of
diagnosed disease and thus included in the predefined exclu-
sion criteria. Reported use of medication for systemic hyper-
tension was the only allowed exception, in otherwise healthy
and asymptomatic eligible subjects. Subjects with abdominal
surgery during the previous 6 months, pregnancy over
20 weeks of gestation or childbirth <3 months prior to the
study visit, were excluded from the study sample. Smoking
history of <10 pack years was allowed if the smoking cessa-
tion had taken place over 10 years previously in order to
accommodate older age cohorts, where prior smoking in
adolescence was known to be more prevalent. Height was
measured without shoes using a calibrated stadiometer to the
closest full cm and weight with only light clothing in kilo-
grams with one decimal. The difference of study date and
subject’s date of birth was used to calculate age truncated to
full years used for calculations.
Identical Vmax 22D spirometers (heated wire flow trans-
ducer spirometer) were used in each study centre (Sensor
Medics Corporation, Yorba Linda, California, USA). Spirome-
ters were calibrated on every day in the morning with a
certified 3-L syringe for volume and flow; three different flow
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levels between 2 and 12 l s1 were used. All the measure-
ments were taken originally following the 1994 ATS Standard
(American Thoracic Society, 1995). A minimum of three suc-
cessive acceptable spirograms were recorded. All data included
are taken from measurements before inhalation of eventual
bronchodilator. During the study, the updated ERS/ATS stan-
dards were issued, which slightly changed, for example the
repeatability criteria (Miller et al., 2005). In the ATS 1994
standard, both forced vital capacity (FVC) and forced expira-
tory volume in 1 s (FEV1) were acceptable, if the two best
values differed no more than 200 ml (American Thoracic
Society, 1995). The ATS/ERS criteria reduced this allowed var-
iation to 150 ml in both volumes (Miller et al., 2005). Of the
total of 1127 subjects eligible for the study sample based on
questionnaire screening, all spirometries were reviewed for
technical acceptability. Subjects not fulfilling the tighter
repeatability criteria were excluded from the study sample.
The final sample was 1000 subjects, 613 women and 387
men.
Table 1 shows descriptive characteristics of anthropometric
measurements of the study sample. The age and height distri-
bution of the study participants is shown in Table 2. A total
of 149 subjects (149%) were classified as eversmokers having
smoked between 01 and 95 pack years with an average of
36 (SD 33) pack years and 284 (SD 103) years from quit-
ting smoking.
Flow-volume spirometry data were extracted electronically
and back verified to the printed copies of spirometry reports.
The largest values of FVC, forced expiratory volume in 6 s
(FEV6) and FEV1 were taken, and their ratios (FEV1/FVC and
FEV1/FEV6) were calculated using these largest values. All
other flow values were taken from the curve with largest
sum of FEV1 + FVC. Data on FEV6 were only available for
measurements taken in Helsinki and Kuopio. The forced
expiratory flow-volume variables analysed include FVC, FEV6,
FEV1, FEV1/FVC, FEV1/FEV6, maximum mid-expiratory flow
(MMEF), maximum expiratory flow at 75%, 50% and 25% of
FVC remaining (MEF75, MEF50, MEF25) and peak expiratory
flow (PEF).
The measured and estimated predicted values were compared
to selected other reference values available from Europe, namely
Switzerland (Br€andli et al., 1996), Norway (Langhammer et al.,
2001), the United Kingdom (Falaschetti et al., 2004), Denmark
(Løkke et al., 2013) and Sweden (Hedenstr€om et al., 1985,
1986) in addition to the GLI2012 (Quanjer et al., 2012),
Viljanen (Viljanen et al., 1982) and ECSC reference values
(Quanjer et al., 1993).
A separate repeatability study was conducted in Helsinki
with 21 healthy volunteers, 6 men and 15 women. The par-
ticipants were on average 403 (SD 99) years old. Spirometry
was repeated on two consecutive days on the same time of
the day (1 h) and undertaken by the same study nurse.
Change in best FVC was on average 0007 (SD 0187) litres
or 01% (SD 36%) from baseline. Change in best FEV1 was
on average 0013 (SD 0098) litres or 05% (SD 39%) from
baseline. FEV1/FVC changed in average 0003 (SD 0017) or
04% (SD 21%) relative to baseline. Only data from the spi-
rometry completed on the first study day were included in the
reference values study.
Statistical methods
All statistical analyses were performed with the R program
(version 2.15.1, http://cran.r-project.org) and using the gam-
lss package (Rigby & Stasinopoulos, 2005; R Core Team,
2012). We applied the generalized additive model for location,
non-smokers
Figure 1 Formation of the study sample in
the four study locations.
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scale and shape (GAMLSS) used also in the modelling of the
Global Lungs Initiative (GLI2012) (Quanjer et al., 2012). The
original LMS method summarizes the changing distribution by
three curves representing the median l (M), coefficient of
variation r (S) and skewness, the latter expressed as after a
Box–Cox power k (L) transformation. The LMS method was
developed by Cole and originally described by Cole & Green,
(1992) (Cole et al., 2009). In our study material, the normal
distribution (NO()) resulted in smaller prediction errors and
the most parsimonious model in terms of the Schwarz Bayesian
Criterion (SBC) than Box–Cox Cole and Green (BCCG) distribu-
tion. Adding a moment for skewness (L) did not significantly
improve the fit of the model in any of the variables. Age
and height were found to be the main determinants in all
evaluated lung function parameters. To allow a flexible model
for the relationship between age and the different spirometric
variables, we used penalized b-splines for age in both the mean
and the standard deviation model. With the normal distribution
gamlss model (NO()), the moment for coefficient of variation
is the standard deviation (Stasinopoulos et al., 2012). Weight
and BMI were assessed separately, but neither provided any
additional degree of explanation to the models.
We used the following prediction equations for the mean
(M) and standard deviation (S) of the lung function variables:
Mi ¼ expða0 þ a1  lnðheightiÞ þ a2  lnðageiÞ þMSplineiÞ;
Si ¼ expðb0 þ b1  lnðageiÞ þ SSplineiÞ;
where a0, a1, a2 and b0, b1 are the regression coefficients esti-
mated from the sample. The values for spline functions MSpli-
nei and SSplinei, for each predicted value, are presented in the
lookup table in Annex S1. The predicted mean value (Mpred)
of each lung function variable can also be expressed as:
Mpred ¼ ea0  heighta1  agea2  eMSpline
The lower limits of normal (LLN) (5th percentile) were
obtained from formula:
LLNi ¼ Mi  1645  Si
Z score for each individual measurement (zi) can be calcu-
lated:
zi ¼ measuredi Mi
Si
Differences between study locations were assessed using a
dummy variable for study location and assessing differences
Table 1 Descriptive statistics of the study population. Values are presented as mean (SD).
Men (n = 387) Women (n = 613)
Mean (SD) Min–max Mean (SD) Min–max
Age (years) 498 (163) 19–82 479 (160) 18–83
Height (m) 177 (007) 153–203 164 (006) 140–180
BMI (m/kg2) 252 (26) 178–300 240 (30) 177–300
FVC (l) 515 (093) 226–734 365 (068) 152–620
FEV6 (l) 492 (101) 224–732 353 (075) 151–620
FEV1 (l) 401 (081) 192–609 291 (061) 120–518
FEV1/FVC (%) 777 (62) 526–954 797 (63) 529–995
FEV1/FEV6 (%) 801 (46) 671–935 813 (51) 642–943
PEF (l s1) 103 (16) 53–181 72 (12) 35–115
MMEF (l s1) 37 (13) 09–81 29 (10) 05–61
MEF75 (l s1) 82 (19) 29–152 59 (13) 24–115
MEF50 (l s1) 44 (14) 13–91 34 (11) 09–74
MEF25 (l s1) 15 (07) 02–44 12 (06) 01–35
BMI, body mass index; FVC, forced vital capacity; FEVt, forced expiratory volume in t seconds, PEF, peak expiratory flow, MMEF, maximum mid-
expiratory flow; MEFx, maximum expiratory flow at x% of FVC remaining.
Table 2 Height and age distribution of study participants.
Age (years)
Men height category (cm) Women height category (cm)
<160 160–169 170–179 180–189 ≥190 All <150 150–159 160–169 170–179 ≥180 All
<30 0 2 25 20 1 48 0 15 56 29 0 100
30–39 0 4 27 45 1 77 1 15 57 34 0 107
40–49 0 2 28 31 5 66 0 26 69 28 1 124
50–59 1 7 37 24 2 71 0 32 70 10 0 112
60–69 1 19 40 12 1 73 2 33 62 6 1 104
≥70 2 17 28 5 0 52 4 40 22 0 0 66
All 4 51 185 137 10 387 7 161 336 107 2 613
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between predictions from different locations. Similarly, a sen-
sitivity analysis was conducted using dichotomous smoking
(never and ever) and obesity (BMI > 30) as dummy variables
in a full gamlss model. No statistically significant differences
were found in the predicted values in terms of smoking or
obesity when sex, age and height of the subjects were taken
into consideration and when using a dummy variable for
study location. Obese subjects were excluded from final models.
Bland–Altman plots for difference between predicted FVC
and FEV1 from this study and those predicted from GLI2012
reference values were plotted as described by Bland and Alt-
man (Bland & Altman, 1986).
Results
The estimated coefficients for the regression equations using
the LMS method are listed separately for each lung function
variable in Table 3. The mean predicted values and their
respective LLN for FEV1, FEV6, FVC and FEV1/FVC and
FEV1/FEV6 ratios are plotted in Fig. 2 for men and women
using arithmetic mean of height of the sample. Bland–Altman
plots for difference between predicted FVC and FEV1 from
this data set and the Global Lungs Initiative 2012 (GLI2012)
reference values in Fig. 3 show that the absolute difference in
predicted values is greater in smaller predicted lung volumes
and decreases with increasing predicted lung volume.
Model predicted mean values from this study compared to
Viljanen reference values (Viljanen et al., 1982) for MEF50
and compared to the GLI2012 reference values (Quanjer et al.,
2012) for MMEF with the respective LLN values are shown in
Fig. 4 as a function of age for average height men and
women. Viljanen reference values markedly overestimate the
MEF50 values. GLI2012 values do not have MEF50 model, but
the MMEF model is closely similar to the predicted model
from our study. The coefficient of variation was larger in
instantaneous flow values (MEF25, MEF50, MEF75) and in
MMEF compared to main variables (FEV1, FVC and FEV1/
FVC).
The difference between measured and predicted values cal-
culated from this data set was in average FEV1 0064 (SD
0101) litres, FVC 0014 (0546) litres and FEV1/FVC
011% (524%). With GLI2012 reference values, the differ-
ences were 0099 (0442) litres, 0205 (0557) litres and
180% (534%), respectively. The difference in predicted
mean and LLN values between the present study and GLI2012
reference values in Fig. 5 demonstrates that the GLI2012 ref-
erence values slightly underestimate both mean FEV1 and FVC
in men and women with an age-dependent increasing trend.
However, the GLI2012 reference values give better agreement
in lung volumes than the ECSC reference values, which
underestimate the FVC and FEV1 by around 04 l (Table 4).
Particularly in women, the ECSC reference values underesti-
mate FVC in this data set on average by 527 ml or 17%. Vilja-
nen reference values on average performed better than the
GLI2012 in both FVC and FEV1 in the applicable age range of
18–65 years. Of other comparable reference values, the
prediction equations from Switzerland (Br€andli et al., 1996)
were closest to the observed distribution, whereas values from
Table 3 Coefficients for predictive equations. Formula for mean (M) = exp(a0 + a1*ln(height) + a2*ln(age) + MSpline) and standard deviation
(S) = exp (b0 + b1*ln(age) + Sspline). For spline contributions to each model, see respective lookup tables
a.
Spirometry variable a0 a1 a2 b0 b1
FVC (l) Men 8903 2165 0173 1652 0319
Women 9278 2214 0188 0219 0149
FEV6 (l) Men 8377 2101 0232 1352 0258
Women 9371 2275 0254 0052 0220
FEV1 (l) Men 7437 1908 0275 1547 0239
Women 7205 1858 0316 0032 0266
FEV1/FVC Men 1673 0292 0108 2643 0065
Women 1869 0311 0135 3076 0023
FEV1/FEV6 Men 1128 0223 0051 1494 0424
Women 1556 0274 0096 2809 0091
PEF (l s1) Men 3402 1172 0086 0596 0248
Women 3733 1211 0123 0462 0104
MMEF (l s1) Men 1741 0984 0539 0545 0139
Women 0240 0701 0607 0804 0308
MEF75 (l s1) Men 1810 0843 0117 0233 0090
Women 2368 0932 0158 0343 0054
MEF50 (l s1) Men 1867 0940 0397 0350 0043
Women 1495 0852 0427 0267 0113
MEF25 (l s1) Men 4195 1512 0859 0463 0303
Women 0123 0761 1031 1961 0779
aHeight in cm, age in years.
FVC, forced vital capacity; FEVt, forced expiratory volume in t seconds; PEF, peak expiratory flow; MMEF, maximum mid-expiratory flow; MEFx,
maximum expiratory flow at x% of FVC remaining.
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Nordic countries such as Denmark (Løkke et al., 2013) and
Norway (Langhammer et al., 2001) underestimated FVC and
overestimated FEV1/FVC. But the old Swedish values of FVC
(Hedenstr€om et al., 1985, 1986) were very close to the new
Finnish values in their age range (Table 4).
The mean z score of FVC in men was 037 (SD 100) when
calculated according the GLI2012 predictions and 003
(SD 100) according the predictions of the present study. For
FEV1/FVC, the values were 023 (080) and 002 (100),
respectively. The predicted model from the present study
compared to the GLI2012 reference values (Quanjer et al.,
2012) for FVC, FEV1 and FEV1/FVC in relation to different
age categories are presented in Fig. 6. Although the mean
difference between measured and predicted GLI2012 reference
value was small, the figure shows a slight trend of increasing
underestimation of FEV1 by age when using GLI2012 predic-
tions. Data calculated according to our new predicted model
compared to those by GLI2012 reference model in different
height categories are shown in Fig. 7; the underestimation of
lung volumes is greater in shorter subjects and decreases with
increasing height.
Discussion
The need for locally representative reference values is of
utmost importance. The old Finnish reference values by
Viljanen (Viljanen et al., 1982) are limited by the relatively
narrow age scale of study subjects, potential cohort effect,
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substantial change in the technical equipment and improve-
ment in statistical methodologies over the past 40 years. In
this study, we evaluated 1000 healthy non-smoking native
Finnish subjects for lung function and found that the recently
published GLI2012 reference values on average provided with
reasonably good fit, but underestimated lung volumes, espe-
cially FVC, with the degree of underestimation gradually
increasing with advancing age.
(a) (b)
Figure 3 Bland–Altman plots of individual differences between predicted values according to present study (Kainu et al.) and predicted values
according to GLI2012 (Quanjer et al., 2012) for forced vital capacity (FVC) (a) and forced expiratory volume in 1 s (FEV1) (b).
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GLI2012 reference values are clearly more representative of
current target population than the ECSC reference values in
lung volumes, but the FEV1/FVC ratio was better predicted
using the ECSC due to the fact that the magnitude of underes-
timation of FEV1 and FVC was similar in the ECSC predictions.
Of other European reference values evaluated, the Swiss
reference values of Br€andli et al. showed best agreement both
in terms of lung volumes and in the FEV1/FVC ratio. How-
ever, significant differences were found between the predicted
GLI2012 values and new locally derived predicted values using
a similar model. The Finnish adults had slightly larger lung
volumes than predicted by the GLI2012 reference values and
also other comparable reference values, with the exception of
the Br€andli et al. values. The found average underestimation of
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Figure 5 Comparison of predicted mean and lower limit of normal (LLN) of (a and b) forced vital capacity (FVC), (b and c) forced expiratory
volume in 1 s (FEV1), and (d and e) FEV1/FVC between GLI2012 (Quanjer et al., 2012) and predicted values from this study. Graphs a, c and e
present values for average height men (177 cm), and graphs b, d and f for average height women (164 cm).
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FEV1 by 3% with GLI2012 can be regarded as significant
given the role of FEV1 in interpretation of spirometry in gen-
eral. FEV1 is the main variable used for clinical decision-mak-
ing and also grading of ventilatory defects in spirometry
according to the ATS/ERS standard (Pellegrino et al., 2005).
Even more importantly, when the two prediction models are
compared on actual reference subjects, the GLI2012 reference
model shows an age-dependent trend of increasing underesti-
mation of FEV1 and particularly FVC especially in men. In
FEV1/FVC this results in an overestimation that increases with
age, which is quite unfortunate given the important role of
FEV1/FVC reference value in the diagnosis of airflow limita-
tion. The SAPALDIA study is one of the studies included in
the GLI models, which showed one of the best concordances,
but which is also limited to the age range 18–60 years. The
number of Nordic subjects was very small in the GLI data set.
The observed difference between native Finns and the
GLI2012 reference values poses several questions and ave-
nues for further study. The GLI2012 model provided better
agreement with younger and taller adults, but predicted
smaller lung volumes with an age-dependent trend. The
older adults, women in particular, were significantly shorter
and also their height varied within the age category less,
that is the older subjects were more homogenous with
respect to size.
It has been proposed that the ratio of sitting height to
standing height, the so-called Cormic index, would be larger
in older age groups. Cormic index and sitting height correlate
better with lung volumes than standing height. However, sit-
ting height or the Cormic index is not commonly measured
in epidemiological studies, not in our study either. The
observed increase in lung volumes in relation to height with
age could be explained by an increasing Cormic index with
age. The maximum attainable height is influenced both from
genetic and environmental effects, with changing environmen-
tal factors affecting heritability (Silventoinen et al., 2000). The
genetic build of the native Finns cannot have changed mark-
edly over decades, but there is a major change in the level of
nutrition and health, which can explain why the GLI2012
values would seem to fit better in the younger age categories.
Table 4 Mean predicted values and mean differences between observed and predicted values in the present study and predicted in some other
European publications. Reference values are applied only to the indicated age ranges of study subjects.
Age group
Men Women
Subjects
n
% Predicted
mean (SD%)
Mean
difference
Subjects
n
% Predicted
mean (SD%)
Mean
difference
FVC (l)
Kainu 18–83 years 387 997 (137) 0017 613 997 (127) 0011
GLI2012 (Quanjer et al., 2012) 3–95 years 387 1062 (156) 0271 613 1051 (139) 0163
Viljanen (Viljanen et al., 1982) 18–65 years 300 1014 (121) 0074 508 1006 (130) 0011
ECSC (Quanjer et al., 1993) 18–69 years 335 1061 (135) 0306 547 1174 (166) 0527
Br€andli (Br€andli et al. 1996) 18–60 years 267 1006 (113) 0032 456 1000 (118) 0002
Falaschetti (Falaschetti et al. 2004) 16–75 years 371 1064 (154) 0284 592 1075 (147) 0234
Hedenstr€om (Hedenstr€om et al. 1985, 1986) 20–70 years 337 1000 (131) 0035 548 983 (132) 0074
Langhammer (Langhammer et al. 2001) 20–80 years 384 1049 (157) 0202 602 1038 (140) 0113
Løkke (Løkke et al. 2013) 20–89 years 384 1090 (162) 0401 602 1051 (138) 0165
FEV1 (l)
Kainu 18–83 years 387 1000 (147) 0002 613 996 (124) 0012
GLI2012 (Quanjer et al., 2012) 3–95 years 387 1042 (164) 0135 613 1030 (131) 0077
Viljanen (Viljanen et al., 1982) 18–65 years 300 977 (121) 0098 508 973 (121) 0096
ECSC (Quanjer et al., 1993) 18–69 years 335 1087 (146) 0320 547 1096 (145) 0244
Br€andli (Br€andli et al. 1996) 18–60 years 267 1015 (121) 0061 456 1011 (115) 0033
Falaschetti (Falaschetti et al. 2004) 16–75 years 371 1050 (161) 0162 592 1047 (136) 0115
Hedenstr€om (Hedenstr€om et al. 1985, 1986) 20–70 years 337 1011 (134) 0063 548 973 (124) 0092
Langhammer (Langhammer et al. 2001) 20–80 years 384 1002 (153) 0008 602 1001 (127) 0004
Løkke (Løkke et al. 2013) 20–89 years 384 1046 (164) 0166 602 1035 (131) 0094
FEV1/FVC (%)
Kainu 18–83 years 387 1001 (72) 01% 613 1002 (64) 01%
GLI2012 (Quanjer et al., 2012) 3–95 years 387 979 (70) 17% 613 977 (64) 19%
Viljanen (Viljanen et al. 1982) 18–65 years 300 965 (70) 29% 508 970 (60) 25%
ECSC (Quanjer et al., 1993) 18–69 years 335 993 (70) 06% 547 997 (64) 03%
Br€andli (Br€andli et al. 1996) 18–60 years 267 1009 (72) 06% 456 1008 (60) 07%
Falaschetti (Falaschetti et al. 2004) 16–75 years 371 971 (69) 23% 592 977 (63) 19%
Hedenstr€om (Hedenstr€om et al., 1985, 1986) 20–70 years 337 1030 (72) 23% 548 1009 (64) 06%
Langhammer (Langhammer et al. 2001) 20–80 years 384 920 (76) 68% 602 972 (69) 23%
Løkke (Løkke et al. 2013) 20–89 years 384 964 (70) 29% 602 982 (66) 14%
SD, standard deviation; FVC, forced vital capacity; ECSC, European Community for Steel and Coal; FEV1, forced expiratory volume in 1 s.
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This also suggests a significant secular trend in Finland, which
can explain the continuing need for national reference values.
In average height men and women, the predicted mean
FEV1/FVC ratio from this study was slightly lower than from
the GLI2012 model, but the LLN was fairly similar except in
the older age categories in men. However, the effect of height
is not uniform in these models, which explains the observed
difference in actual subjects and the models for average height
adults. The mean height of the youngest age groups was
approximately 9 cm taller in both men and women compared
to the oldest age groups. The effect of height on the predicted
FEV1/FVC was larger in our models than in the GLI2012
models. The FEV1/FVC ratio is pivotal in the diagnosis of
obstruction, but FEV1 is highly significant in the grading of
reductions in lung function both in obstructive and restrictive
disorders – also in international guidelines for diagnosis and
management of major obstructive airways diseases particularly
chronic obstructive pulmonary disease (Pellegrino et al., 2005;
Bousquet et al., 2007; Vestbo et al., 2012).
The proportion of male subjects in the study was relatively
small (39%). This was partially due to relatively more fre-
quent disqualification due to reported smoking exposure and
respiratory symptoms. Also, younger men were less likely to
participate in the study (Kotaniemi et al., 2001). The absolute
numbers and age distribution of the male subjects was judged
to be adequate for the current analysis. In addition, to exclude
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Figure 6 Comparison of z scores of pre-
dicted a) forced vital capacity (FVC), b)
forced expiratory volume in 1 s (FEV1) and
c) their ratio FEV1/FVC predicted from the
present study and the GLI2012 (Quanjer et al.,
2012) reference models in different age cate-
gories for men and women in the reference
data set.
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the potential selection bias introduced by selection criteria,
each spirometry variable was separately assessed for differ-
ences between study locations using a dummy variable for
study location in the GAMLSS model. No statistically signifi-
cant differences were found when gender, age and height of
the subjects were taken into consideration. As the study centre
in Kuopio recruited more older subjects than the other
centres, all subjects over 60 years of age were excluded in a
further effort to rule out selection bias affecting the found
age-related increase in model discordance with the GLI2012
prediction model. The sampling differences between the study
centres did not seem to significantly affect the prediction
models.
To get more elderly subjects for the study, the newspaper
announcements to recruit volunteers were targeted in Kuopio
to papers frequently read by senior citizens. In the older age
cohorts, it was recognized that short smoking exposure dur-
ing, for example, war years by older men could make the
recruitment of healthy older subjects unnecessarily difficult.
Thus, it was decided a priori that <10 pack years of smoking
was allowed, if smoking cessation took place at least 10 years
previously. The smoking criteria were implemented strin-
gently, thus also excluding a larger number of young men
that had more often casual or short-term smoking, but with
smoking cessation invariably <10 years previously.
The effect of including some eversmokers to the model was
assessed in a separate sensitivity analysis which showed that
the results obtained from eversmokers (n = 149) in this study
did not differ from neversmokers with the exception of ever-
smokers being significantly older, given the required 10-year
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Figure 7 Comparison of z scores of predicted (a and b) forced vital capacity (FVC), (c and d) forced expiratory volume in 1 s (FEV1), and (e
and f) their ratio FEV1/FVC predicted from the present study and the GLI2012 (Quanjer et al., 2012) reference models in different height catego-
ries. Graphs a, c and e for men, and b, d and f for women in the reference data set.
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interval from smoking cessation. The majority of eversmokers
had smoked in their teenage years. The mean age of quitting
smoking was 19 years with an average time 284 years from
quitting smoking. This was the result of predefined criteria
and not actually anticipated, but the exclusion of these sub-
jects would have resulted in an additional selection bias.
Careful sensitivity analyses were conducted to rule out
selection bias on grounds of smoking exposure, obesity and
the different selection procedures in the four locations. The
selection criteria from the population studies were predefined
and the subjects from Kuopio and Tampere recruited using
similar criteria. During the study, new simplified criteria were
suggested in the literature for selection of subjects for lung
function reference values (Johannessen et al., 2007). As our
criteria had been predefined for subject selection in the tar-
geted recruitment, these new criteria could not be applied in
this study. However, we find these criteria fairly similar.
Technical differences between the rolling-seal spirometer
used by Viljanen and the pneumotachograph sensors used in
our measurements and small number of subjects over 60 years
of age in the Viljanen study offer an explanation to the
observed overestimation of MEF50 in the old Finnish reference
values (Viljanen et al., 1982). For MMEF, the new GLI2012 val-
ues were very similar to our new values despite larger inherent
variability of the instantaneous flow values. The instantaneous
flow values provide additional information to complement
main indexes and if used, should always be derived from the
same data set and manoeuvres as the main variables.
GLI2012 reference values present one set of reference values
for all Caucasians broadly defined as all European decent ori-
gins. Significant genetic differences exist between different
European populations and from studies among twins for FEV1
additive genetic effects of 61% have been observed (Jakkula
et al., 2008; Ingebrigtsen et al., 2011). Comparative studies on
healthy subjects have not been undertaken, but it has been
hypothesized that the northern populations would have
slightly larger lung volumes. In Tunis, which is categorized
into the same ‘Caucasian’ ethnic group with Finland, the
GLI2012 values have been shown to overestimate lung vol-
umes, with mean z scores of 062 (SD 086) for FVC and
055 (SD 087) for FEV1 (Ben Saad et al., 2013). In our
study, the same GLI2012 prediction model underestimated
FVC with mean z score of +037 (SD 100) and FEV1 + 025
(SD 104). In our study, the difference with the GLI2012
prediction was largest in the older age groups and in sub-
jects with short stature. The new Finnish reference values
present the current level of lung function for Finnish adults
18–80 years of age.
Conclusions
The present new reference values offer a closer prediction of
spirometric values for native Finns than any other published
predictions, including the GLI2012 reference values, which
underestimated lung volumes with an age-dependent trend.
Therefore, we recommend these new Finnish reference values
of flow-volume spirometry for clinical use among native
Finns.
Acknowledgments
The HEVI Project has been funded from Tampere Tuberculosis
Foundation. The FinEsS-Helsinki study has received funding
from the Special Governmental Subsidy for Health Sciences
Research (project codes TYH2013354, TYH1235, TYH 2303
and TYH 4251). Dr Annette Kainu has received a research
grant from the Finnish Antituberculosis Foundation and Jal-
mari and Rauha Ahokas Foundation.
We warmly thank registered nurse Pirjo Luostarinen in
Kuopio University Hospital for making the lung function
measurements and coordinating the study in Kuopio. Dr
Marjaana Sipil€a, MD, is warmly thanked for undertaking the
lung function measurements in Tampere. The Research Unit
of Pulmonary Medicine in Helsinki University Central
Hospital is thanked for high-quality measurements and
undertaking the FinEsS-Helsinki study. Ms Jaana Jouhten,
BM, is acknowledged for her technical assistance on screen-
ing the repeatability of individual measurements from the
four study centres.
Conflict of interest
The authors have no conflicts of interest pertaining to this
manuscript.
References
American Thoracic Society. Standardization of
spirometry. 1994 Update. Am J Respir Crit
Care Med (1995); 152: 1107–1136.
Ben Saad H, El Attar MN, Mabrouk KH, et al.
The recent multi-ethnic global lung initiative
2012 (GLI2012) reference values don’t reflect
contemporary adult’s North African spirome-
try. Resp Med (2013); 107: 2000–2008.
Bland JM, Altman DG. Statistical methods for
assessing agreement between two methods.
Lancet (1986); 1: 307–310.
Bousquet J, Clark TJ, Hurd S, et al. GINA
guidelines on asthma and beyond. Allergy
(2007); 62: 102–112.
Br€andli O, Schindler Ch, K€unzli N, et al. Lung
function in healthy never smoking adults: refer-
ence values and lower limits of normal of a
Swiss population. Thorax (1996); 51: 277–283.
Cole TJ, Green PJ. Smoothing reference cen-
tile curves: the LMS method and penalized
likelihood. Stat in Med (1992); 11: 1305–
1319.
Cole TJ, Stanojevic S, Stocks J, et al. Age- and
size-related reference ranges: a case study
of spirometry through childhood and
adulthood. Statist Med (2009); 28: 880–
898.
Falaschetti E, Laiho J, Primatesta P, et al.
Prediction equations for normal and low
lung function from the Health Survey for
England. Eur Respir J (2004); 23: 456–463.
Hall GL, Thompson BR, Stanojevic S, et al.
The Global Lung Initiative 2012 reference
© 2015 The Authors. Clinical Physiology and Functional Imaging published by John Wiley & Sons Ltd on behalf of Scandinavian Society of Clinical
Physiology and Nuclear Medicine. 36, 5, 346–358
Finnish spirometry reference values, A. Kainu et al. 357
values reflect contemporary Australasian
spirometry. Respirology (2012); 17: 1150–
1151.
Hedenstr€om H, Malmberg P, Agarwal K. Ref-
erence values for lung function tests in
females. Regression equations with smoking
variables. Bulletin Europeen de Physiopathologie Res-
piratoire (1985); 21: 551–557.
Hedenstr€om H, Malmberg P, Fridriksson HV.
Reference values for lung function tests in
men: regression equations with smoking
variables. Upsala J Med Sci (1986); 91: 299–
310.
Ingebrigtsen TS, Thomsen SF, var der Sluis S,
et al. Genetic influences on pulmonary func-
tion: a large sample twin study. Lung
(2011); 189: 323–330.
Jakkula E, Rehnstr€om K, Varilo T, et al. The
genome-wide patterns of variation expose
significant substructure in a founder popula-
tion. Am J Human Gen (2008); 83: 787–794.
Johannessen A, Omenaas ER, Eide GE, et al.
Feasible and simple exclusion criteria for
pulmonary reference populations. Thorax
(2007); 62: 792–798.
Kainu A, Lindqvist A, Sarna S, et al. FEV1
response to bronchodilation in an adult
urban population and in healthy adults.
Chest (2008); 134: 387–393.
Kotaniemi JT, Hassi J, Kataja M, et al. Does
non-responder bias have a significant effect
on the results in a postal questionnaire
study? Eur J Epidemiol (2001); 17: 809–817.
Kotaniemi J-T, Sovij€arvi A, Lundb€ack B.
Chronic obstructive pulmonary disease in
Finland: prevalence and risk factors. COPD
(2005); 3: 331–339.
Langhammer A, Johnsen R, Gulsvik A, et al.
Forced spirometry reference values for Nor-
wegian adults: the Bronchial Obstruction in
Nord-Trøndelag study. Eur Respir J (2001);
18: 770–779.
Løkke A, Marott JL, Mortensen J, et al. New
Danish reference values for spirometry. Clin
Respir J (2013); 7: 153–167.
Miller MR, Hankinson J, Brusasco V, et al.
ATS/ERS Task Force: standardisation of lung
function testing. Standardisation of spirome-
try. Eur Respir J (2005); 26: 319–338.
Pallasaho P, R€onmark E, Haahtela T, et al.
Degree and clinical relevance of sensitiza-
tion to common allergens among adults: a
population study in Helsinki, Finland. Clin
Exp Allergy (2006); 36: 503–509.
Pellegrino R, Viegi G, Brusasco V, et al. ATS/
ERS Task Force: standardisation of lung
function testing. Interpretative strategies for
lung function tests. Eur Respir J (2005); 26:
948–968.
Quanjer PH, Tammeling GJ, Cotes JE, et al.
Lung volumes and forced ventilatory flows.
Report Working Party Standardization of
Lung Function Tests, European Community
for Steel and Coal. Official Statement of the
European Respiratory Society. Eur Respir J
(1993); 6(Suppl. 16): 5–40.
Quanjer PH, Stanojevic S, Cole TJ, et al. ERS
Task Force. Multi-ethnic reference values
for spirometry for the 3-95-yr age range:
the global lung function 2012 equations.
Eur Respir J (2012); 40: 1324–1343.
Quanjer PH, Brazzale DJ, Boros PW, et al.
Implications of adopting the Global Lungs
Initiative 2012 all-age reference equations
for spirometry. Eur Respir J (2013); 42:
1046–1054.
R Core Team (2012). R: A Language and Environ-
ment for Statistical Computing. R Foundation for
Statistical Computing, Vienna, Austria. ISBN
3-900051-07-0, URL http://www.R-pro-
ject.org/.
Rigby RA, Stasinopoulos DM. Generalized
additive models for location, scale and
shape. Appl Statist (2005); 54: 507–554.
Silventoinen K, Lahelma E, Rahkonen O. Social
background, adult body-weight and health.
Int J of Epid (1999); 28: 911–918.
Silventoinen K, Kaprio J, Lahelma E, et al. Rel-
ative effect of genetic and environmental
factors on body height: differences across
birth cohorts among Finnish men and
women. Am J Public Health (2000); 90: 627–
630.
Stanojevic S, Wade A, Stocks J, et al. Reference
ranges for spirometry across all ages. A new
approach. Am J Respir Crit Care Med (2008);
177: 253–260.
Stasinopoulos M, Rigby B, Akantziliotou C.
Instructions on how to use the gamlss package
in R. Second edition. 2012. URL http://
www.gamlss.org/wp-content/uploads/2013/
01/gamlss-manual.pdf
Vestbo J, Hurd SS, Rodriquez-Roisin R. The
2011 revision of the global strategy for the
diagnosis, management and prevention of
COPD (GOLD) – why and what? Clin Resp J
(2012); 6: 208–214.
Viljanen AA, Halttunen PK, Kreus K-E, et al.
Spirometric studies in non-smoking, healthy
adults. Scand J Clin Lab Invest (1982); 42(Sup-
pl. 159): 5–20.
Supporting Information
Additional Supporting Information may
be found in the online version of this
article:
Appendix S1. Coefficients for predictive
equations. Formula for mean (M)= exp
(a0+ a1*ln(height)+ a2*ln(age)+MSpline)
and standard deviation (S)= exp (b0+
b1*ln(age)+ Sspline). For spline contribu-
tions to each model, see respective
lookup tables.
© 2015 The Authors. Clinical Physiology and Functional Imaging published by John Wiley & Sons Ltd on behalf of Scandinavian Society of Clinical
Physiology and Nuclear Medicine. 36, 5, 346–358
Finnish spirometry reference values, A. Kainu et al.358
